Left atrial volume is associated with inflammation and atherosclerosis in patients with kidney disease

Echocardiography

Volumn 25, Issue 3, 2008, Pages 264-269

  Rao, Anupama K ^a   Djamali, Arjang ^a   Korcarz, Claudia E ^a   Aeschlimann, Susan E ^a   Wolff, Matthew R ^a   Stein, James H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Kidney disease; Left atrium; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY SURFACE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART VENTRICLE FILLING; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MITRAL E WAVE; MITRAL VALVE REGURGITATION; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STROKE; TRANSTHORACIC ECHOCARDIOGRAPHY; WAVEFORM;

ATRIAL FUNCTION, LEFT; CAROTID ARTERIES; CAROTID ARTERY DISEASES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK FACTORS;

EID: 40149106662     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2007.00589.x     Document Type: Article

References (27)

1. Tsang TS, Abhayaratna WP, Barnes ME, et al: Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J Am Coll Cardiol 2006 47: 1018 1023.
2. Tsang TS, Barnes ME, Gersh BJ, et al: Prediction of risk for first age-related cardiovascular events in an elderly population: The incremental value of echocardiography. J Am Coll Cardiol 2003 42: 1199 1205.
3. Barnes ME, Miyasaka Y, Seward JB, et al: Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 2004 79: 1008 1014.
4. Takemoto Y, Barnes ME, Seward JB, et al: Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 2005 96: 832 836.
5. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351: 1296 1305.
6. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998 32: S112 S119.
7. Silberberg JS, Barre PE, Prichard SS, et al: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989 36: 286 290.
8. Silberberg JS, Rahal DP, Patton DR, et al: Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. Am J Cardiol 1989 64: 222 224.
9. Simek CL, Feldman MD, Haber HL, et al: Relationship between left ventricular wall thickness and left atrial size: Comparison with other measures of diastolic function. J Am Soc Echocardiogr 1995 8: 37 47.
10. Tripepi G, Benedetto FA, Mallamaci F, et al: Left atrial volume in end-stage renal disease: A prospective cohort study. J Hypertens 2006 24: 1173 1180.
11. Lester SJ, Ryan EW, Schiller NB, et al: Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 1999 84: 829 832.
12. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 18: 1440 1463.
13. Stein JH, Fraizer MC, Aeschlimann SE, et al: Vascular age: Integrating carotid intima-media thickness measurements with global coronary risk assessment. Clin Cardiol 2004 27: 388 392.
14. Abhayaratna WP, Seward JB, Appleton CP, et al: Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol 2006 47: 2357 2363.
15. Menon V, Greene T, Wang X, et al: C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005 68: 766 772.
16. Psychari SN, Apostolou TS, Sinos L, et al: Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005 95: 764 767.
17. Hatzinikolaou-Kotsakou E, Tziakas D, Hotidis A, et al: Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 2006 97: 659 661.
18. Dernellis J, Panaretou M: C-reactive protein and paroxysmal atrial fibrillation: Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001 56: 375 380.
19. Anne W, Willems R, Roskams T, et al: Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005 67: 655 666.
20. Xu J, Cui G, Esmailian F, et al: Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004 109: 363 368.
21. Lorenz MW, Karbstein P, Markus HS, et al: High-sensitivity C-reactive protein is not associated with carotid intima-media progression: The carotid atherosclerosis progression study. Stroke 2007 38: 1774 1779.
22. Hunt ME, O'Malley PG, Vernalis MN, et al: C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001 141: 206 210.
23. Rifai N, Joubran R, Yu H, et al: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 1999 45: 1967 1973.
24. Reynolds GD, Vance RP: C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987 111: 265 269.
25. Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107: 499 511.
26. Wang M, Yip GW, Wang AY, et al: Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003 41: 820 826.
27. Benjamin EJ, D'Agostino RB, Belanger AJ, et al: Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995 92: 835 841.